Kyrtsonis, Maria-Christina <br/><br/>
Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.  [electronic resource] 

 -  European journal of haematology  Apr 2004 
 - 252-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0902-4441 
<br/><br/><label>Standard No.: </label>10.1046/j.0902-4441.2003.00205.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biomarkers, Tumor--blood<br/>Bone Resorption--blood<br/>Cyclophosphamide--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Diphosphonates--therapeutic use<br/>Doxorubicin--administration & dosage<br/>Female<br/>Fibroblast Growth Factor 2--blood<br/>Follow-Up Studies<br/>Glycoproteins--blood<br/>Humans<br/>Life Tables<br/>Male<br/>Melphalan--administration & dosage<br/>Membrane Glycoproteins--blood<br/>Middle Aged<br/>Multiple Myeloma--blood<br/>Neoplasm Proteins--blood<br/>Neoplasm Staging<br/>Neovascularization, Pathologic--blood<br/>Osteoprotegerin<br/>Pamidronate<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Proteoglycans--blood<br/>Receptors, Cytoplasmic and Nuclear--blood<br/>Receptors, Tumor Necrosis Factor<br/>Survival Analysis<br/>Syndecan-1<br/>Syndecans<br/>Vincristine--administration & dosage<br/>beta 2-Microglobulin--analysis